Cleaved-tau: A biomarker of neuronal damage after traumatic brain injury

Journal of Neurotrauma

Volumn 22, Issue 1, 2005, Pages 83-94

  Gabbita, S Prasad ^a   Scheff, Stephen W ^b   Menard, Renee M ^a   Roberts, Kelly ^b   Fugaccia, Isabella ^b   Zemlan, Frank P ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Axon; Cleaved tau (C tau); Controlled cortical impact (CCI); Cyclosporin A; Microtubule associated protein tau (MAP tau); Neuron, traumatic brain injury (TBI)

Indexed keywords

BIOLOGICAL MARKER; CYCLOSPORIN A; TAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN INJURY; BRAIN LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; HIPPOCAMPUS; HISTOPATHOLOGY; MALE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN FUNCTION; RAT;

EID: 12544250259     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2005.22.83     Document Type: Article

References (42)

1. ANNEGERS, J.F., GRABOW, J.D., KURLAND, L.T., and LAWS E.R. (1980). The incidence, causes, and secular trends of head trauma in Olmsted County, Minnesota, 1935-1974. Neurology 30, 912-919.
2. BEER, R., FRANZ, G., KRAJEWSKI, S., et al. (2001). Temporal and spatial profile of caspase 8 expression and proteolysis after experimental traumatic brain injury. J. Neurochem. 78, 862-873.
3. BINDER, L.I., FRANKFURTER, A., and REBHUN, L.I. (1985). The distribution of tau in the mammalian central nervous system. J. Cell Biol. 101, 1371-1378.
4. FASULO, L., UGOLINI, G., VISINTIN, M., et al. (2000). The neuronal microtubule-associated protein tau is a substrate for caspase-3 and an effector of apoptosis. J. Neurochem. 75, 624-633.
5. GOEDERT, M., SPILLANTINI, M.G., JAKES, R., RUTHERFORD, D., and CROWTHER, R.A. (1989). Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3, 519-526.
6. HOFFMAN, P.N., and LASEK, R.J. (1975). The slow component of axonal transport. Identification of major structural polypeptides of the axon and their generality among mammalian neurons. J. Cell Biol. 66, 351-366.
7. IRAZUZTA, J.E., DE COURTEN-MYERS, G., ZEMLAN, F.P., BEKKEDAL, M. Y., and ROSSI, G., III. (2001). Serum cleaved Tau protein and neurobehavioral battery of tests as markers of brain injury in experimental bacterial meningitis. Brain Res. 913, 95-105.
8. KAMPFL, A., POSMANTUR, R.M., ZHAO, X., SCHMUTZ-HARD, E., CLIFTON, G.L., and HAYES, R.L. (1997). Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: implications for pathology and therapy: a review and update. J. Neurotrauma 14, 121-134.
9. KOSIK, K.S., and FINCH, E.A. (1987). MAP2 and tau segregate into dendritic and axonal domains after the elaboration of morphologically distinct neurites: an immunocytochemical study of cultured rat cerebrum. J. Neurosci. 7, 3142-3153.
10. LENZLINGER, P.M., MORGANTI-KOSSMANN, M.C., LAURER, H.L., and McINTOSH, T.K. (2001). The duality of the inflammatory response to traumatic brain injury. Mol. Neurobiol. 24, 169-181.
11. LITMAN, P., BARG, J., RINDZOONSKI, L., and GINSBURG, I. (1993). Subcellular localization of tau mRNA in differentiating neuronal cell culture: implications for neuronal polarity. Neuron 10, 627-638.
12. MARSHALL, L.F. (2000). Epidemiology and cost of central nervous system injury. Clin. Neurosurg. 46, 105-112.
13. MAX, W., MACKENZIE, E.J., and RICE, D.P. (1991). Head injuries: Costs and consequences. J. Head Trauma Rehabil. 6, 76-87.
14. MAXWELL, W.L., POVLISHOCK, J.T., and GRAHAM, D.L. (1997). A mechanistic analysis of nondisruptive axonal injury: a review. J. Neurotrauma 14, 419-440.
15. McINTOSH, T.K., SAATMAN, K.E., RAGHUPATHI, R., SMITH, D.H. LEE, V.M., and TROJANOWSKI, J.Q. (1998). The Dorothy Russell Memorial Lecture. The molecular and cellular sequelae of experimental traumatic brain injury: pathogenetic mechanisms. Neuropathol. Appl. Neurobiol 24, 251-267.
16. McMAHAN, B.T., and FLOWERS, S.M. (1986). The high cost of a bump on the head. Business and Health 3, 47-48.
17. MORGANTI-KOSSMANN, M.C., RANCAN, M., OTTO, V.I., STAHEL, P.F., and KOSSMANN, T. (2001). Role of cerebral inflammation after traumatic brain injury: a revisited concept. Shock 16, 165-177.
18. MORRISON, B., III, SAATMAN, K.E., MEANEY, D.F., and McINTOSH, T.K. (1998). In vitro central nervous system models of mechanically induced trauma: a review. J. Neurotrauma 15, 911-928.
19. OKONKWO, D.O., BUKI, A., SIMAN, R., and POVLISHOCK, J.T. (1999a). Cyclosporin A limits calcium-induced axonal damage following traumatic brain injury: an intrathecal bolus of cyclosporin A before injury preserves mitochondrial integrity and attenuates axonal disruption in traumatic brain injury. Neuroreport 10, 353-358.
20. OKONKWO, D.O., and POVLISHOCK, J.T. (1999b). An intrathecal bolus of cyclosporin A before injury preserves mitochondrial integrity and attenuates axonal disruption in traumatic brain injury. J. Cereb. Blood Flow Metab. 19, 443-451.
21. PLEINES, U.E., MORGANTI-KOSSMANN, M.C., RANCAN, M., JOLLER, H., TRENTZ, O., and KOSSMANN, T. (2001). S-100β reflects the extent of injury and outcome, whereas neuron specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J. Neurotrauma 18, 491-498.
22. POVLISHOCK, J.T. (1993). Pathobiology of traumatically induced axonal injury in animals and man. Ann. Emerg. Med. 22, 980-986.
23. RAABE A., GROLMS, C., SORGE, O., ZIMMERMANN, M., and SEIFERT, V. (1999). Serum S-100β protein in severe head injury. Neurosurgery 45, 477-483.
24. RAFF, M.C., WHITMORE, A.V., and FINN, J.T. (2002). Axonal self-destruction and neurodegeneration. Science 296, 868-871.
25. ROTHOERL, R.D., BRAWANSKI, A., and WOERTGEN, C. (2000). S-100B perotein serum levels after controlled cortical impact injury in the rat. Acta Neurochir. 142, 199-203.
26. SCALLET, A.C. (1995). Quantitative histological evaluation of neuroprotective compounds. Ann. N.Y. Acad. Sci. 765, 47-58.
27. SCHEFF, S.W., BALDWIN, S.A., BROWN, R.W., and KRAEMER, P.J. (1997). Morris water maze deficits in rats following traumatic brain injury: lateral controlled cortical impact. J. Neurotrauma 14, 615-627.
28. SCHEFF, S.W., and SULLIVAN, P.G. (1999). Cyclosporin A significantly ameliorates cortical damage following experimental traumatic brain injury in rodents. J. Neurotrauma 16, 783-792.
29. SHAVELLE, R.M., STRAUSS, D., WHYTE, J., DAY, S.M., and Yu, Y.L. (2001). Long-term causes of death after traumatic brain injury. Am. J. Phys. Med. Rehabil. 80, 510-516.
30. SHAW, G.J., JAUCH, E.C., and ZEMLAN, F.P. (2002). Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury. Ann. Emerg. Med. 39, 254-257.
31. SULLIVAN, P.G., THOMPSON, M.B., and SCHEFF, S.W. (1999). Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury. Exp. Neurol. 160, 226-234.
32. SULLIVAN, P.G., RABCHEVSKY, A.G., HICKS, R.R., GIBSON, T.R., FLETCHER-TURNER, A., and SCHEFF, S.W. (2000a). Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats. Neuroscience 101, 289-295.
33. SULLIVAN, P.G., THOMPSON, M., SCHEFF, S.W., and THOMPSON, M.B. (2000b). Continuous infusion of cyclosporin A postinjury significantly ameliorates cortical damage following traumatic brain injury in rodents. Exp. Neurol. 161, 631-637.
34. SULLIVAN, P.G., KELLER, J.N., BUSSEN, W.L., and SCHEFF, S.W. (2002). Cytochrome c release and caspase activation after traumatic brain injury. Brain Res. 949, 88-96.
35. TOWBIN, H., STAEHELIN, T., and GORDON, J. (1992). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology 24, 145-149.
36. WALLACE, T.L., VORHEES, C.V., ZEMLAN, F.P., and GUDELSKY, G.A. (2003). Methamphetamine enhances the cleavage of the cytoskeletal protein tau in the rat brain. Neuroscience 116, 1063-1068.
37. WOERTGEN, C., ROTHOERL, R.D., and BRAWANSKI, A. (2001). Neuron-specific enolase serum levels after controlled cortical impact injury in the rat. J. Neurotrauma 18, 569-573.
38. WOERTGEN, C., ROTHOERL, R. D., WIESMANN, M., MISSLER, U., and BRAWANSKI, A. (2002). Glial and neuronal serum markers after controlled cortical impact injury in the rat. Acta Neurochir. Suppl. 81, 205-207.
39. ZEMLAN, F.P., ROSENBERG, W.S., LUEBBE, P.A., et al. (1999). Quantification of axonal damage in traumatic brain injury: affinity purification and characterization of cerebrospinal fluid tau proteins. J. Neurochem. 72, 741-750.
40. ZEMLAN, F.P., JAUCH, E.C., MULCHAHEY, J.J., et al. (2002). C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome. Brain Res. 947, 131-139.
41. ZEMLAN, F.P., MULCHAHEY, J.J., and GUDELSKY, G.A. (2003). Quantification and localization of kainic acid induced-neurotoxicity employing a new biomarker of cell death: cleaved MAP-tau (C-tau). Neuroscience 121, 399-409.
42. ZINK, B.J. (2001). Traumatic brain injury outcome: concepts for emergency care. Ann. Emerg. Med. 37, 318-332.